According to FutureWise analysis the market for Antihyperlipidemic Drugs in 2023 is US$ 12.76 billion, and is expected to reach US$ 20.83 billion by 2031 at a CAGR of 6.30%.
Antihyperlipidemic drugs are medications that help reduce the cholesterol levels. It also helps improve the cholesterol levels. Antihyperlipidemic drugs also lower serum levels of cholesterol and different lipids. They are also known as lipid-lowering agents; these drugs provide adequate treatment for hyperlipidemia (increased lipid level in the blood). The prevalence of coronary artery disease (CAD) is the most common cause of death among adults and is higher in individuals with hyperlipidemia. High level of lipids and triglyceride is associated with metabolic syndrome consisting of insulin resistance, abdominal obesity, hypertension, and proinflammatory and prothrombotic states.
There are different types of antihyperlipidemic drugs, which include bile acid sequesters, cholesterol absorption inhibitors, PCSK9 inhibitors, fibrates, miscellaneous (antihyperlipidemic agents), and statins. Bile acid sequestrants are a cholesterol-lowering drug that works inside the intestine by attaching to bile, a greenish fluid produced by the liver containing cholesterol that helps in food digestion. The binding process means that less cholesterol is available in the body. Resins lower LDL cholesterol and give a slight boost to HDL cholesterol levels. In addition, PCSK9 inhibitors attach to a specific protein on the surface of liver cells, which results in lowered LDL ("bad") cholesterol. This can be taken as the class of drug with statins. Also, Statins are one of the better-known types of cholesterol-lowering drugs. Healthcare experts choose these for most individuals because they work well and are considered first-line treatment for most individuals with high cholesterol.
FutureWise Market Research has published a report that provides an insightful analysis antihyperlipidemic drugs market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, antihyperlipidemic drugs market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.